| Literature DB >> 33398599 |
Abstract
Histone deacetylases (HDACs) are important epigenetic regulators that mediate deacetylation of both histone and non-histone proteins. HDACs, especially class I HDACs, are highly expressed in developing kidney and subject to developmental control. HDACs play an important role in kidney formation, especial nephron progenitor maintenance and differentiation. Several lines of evidence support the critical role of HDACs in the development and progression of various kidney diseases. HDAC inhibitors (HDACis) are very effective in the prevention and treatment of kidney diseases (including kidney cancer). A better understanting of the molecular mechanisms underlying the role(s) of HDACs in the pathogenesis and progression of renal disease are likely to be of great help in developing more effective and less toxic selective HDAC inhibitors and combinatorial therapeutics.Entities:
Keywords: Histone deacetylase inhibitors; Histone deacetylases; Kidney cancer; Kidney disease
Year: 2021 PMID: 33398599 PMCID: PMC7925501 DOI: 10.1007/s10157-020-01995-5
Source DB: PubMed Journal: Clin Exp Nephrol ISSN: 1342-1751 Impact factor: 2.801